Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Borofalan is a radiation sensitizer that contains 10B, a stable isotope of boron.1 It sensitizes B16/F10 melanoma cells to fast and thermal neutron radiation when used at a concentration of 50 µg/ml. Borofalan (300 mg/kg) selectively accumulates in sarcoma tissues over blood, muscle, skin, liver, and brain tissue in rats.2 In vivo, borofalan (803 mg/kg), in combination with radiation, increases mean survival time in an F98 rat glioma model.3 Formulations containing borofalan have been used in boron neutron capture therapy (BNCT) of unresectable, locally recurrent head and neck cancer.
WARNING This product is not for human or veterinary use.
1. In vitro radiobiological analysis of 10B-
2. Selective delivery of 10B to soft tissue sarcoma using 10B-
3. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent. Radiat. Res. 137(1), 44-51 (1994).